1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EXELIXIS INC
43.37 3.00 (7.43%)
9.4M

XNAS 23 Jun, 2025 5:30 PM (EDT)

Postive Trial
Exelixis rises on Monday as its cancer drug combo shows positive results in phase-3 trial See details